Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 10.75
+0.66 (6.54%)
At close: Mar 6, 2026
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.64 billion as of March 6, 2026. Its market cap has decreased by -64.36% in one year.
Market Cap
3.64B
Enterprise Value
4.13B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.75
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.64B, an increase of 2,295.53%. That is a compound annual growth rate of 46.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.81B |
| Neuren Pharmaceuticals | 1.56B |
| PYC Therapeutics | 1.40B |
| Clarity Pharmaceuticals | 1.29B |
| Opthea | 738.77M |
| Immutep | 560.01M |
| Clinuvel Pharmaceuticals | 509.04M |
| Racura Oncology | 446.99M |